UnitedHealth Group Incorporated

UNH
$425.36 (- $1.18 - 0.28%)
Last updated: 2026-07-03 03:12 UTC
UNH Metrics
Exchange
🇺🇸 NYSE XNYS
New York Stock Exchange, Inc.United StatesAmerica/New_York
SectorHealthcare
IndustryHealthcare Plans
ISINUS91324P1021
CUSIP91324P102
Market Price425.36
Dividend Yield 2.18%
Dividend Growth
1Y +5.17%
3Y +11.81%
5Y +14.59%
10Y +22.76%
Annual Dividend 8.95
Latest Payout ($)2.21
Latest Payout Date2025-12-16
Dividend FrequencyQuarterly
P/E Ratio30.12
EPS19.22
Market Cap$322.7B
Book Value105.72
Price to Book3.139
Beta-0.43
52w High404.15
52w Low234.6
Next Earnings DateN/A

UnitedHealth Group Incorporated trades under ticker UNH on NYSE as a stock. Use this page to review stock price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US91324P1021, CUSIP 91324P102.

About the Company
UnitedHealth Group Incorporated is an American multinational health care company headquartered in Eden Prairie, Minnesota, founded in 1974. It operates through two primary brands: UnitedHealthcare, which provides health insurance and managed care services, and Optum, which delivers health care services, technology, and data analytics. UnitedHealthcare offers benefit plans for employers, individuals, Medicare and retirement members, community and state programs including Medicaid, and global markets in South America. Optum encompasses OptumHealth for care delivery, wellness, and health financial services; OptumInsight for data analytics and consultancy; and OptumRx for pharmacy benefit management. The company serves patients, providers, payers, employers, and public-sector entities across the United States and internationally, focusing on care management, consumer engagement, and improving health system efficiency. UnitedHealth Group Incorporated plays a central role in the health care sector by integrating insurance with innovative services and technology solutions.
Price History
Latest News for UNH
SCHD Just Made Big Changes. Is This Dividend Growth ETF Still a Buy?
The Schwab U.S. Dividend Equity ETF (NYSEARCA:SCHD) stands as one of the most popular dividend-growth vehicles on the market. Since its inception on October 20, 2011, the fund has delivered a cumulative total return of 478%, equating to a 13.3% annualized average. With a current yield of 3.3%, SCHD has turned a hypothetical $10,000 investment ... SCHD Just Made Big Changes. Is This Dividend Growth ETF Still a Buy?
Single Stocks Are Driving the Tape – Direxion Launches Four 2X Bull ETFs
2X Exposure to ADBE, PYPL, TXN, and UNH for Catalyst-Driven Trades Direxion.com Direxion.com New York, New York, March 25, 2026 (GLOBE NEWSWIRE) -- Direxion, a leading provider of Single Stock Leveraged & Inverse ETFs, today announced the launch of four new ETFs offering 2X daily exposure to Adobe Inc. (ADBE), PayPal Holdings Inc. (PYPL), Texas Instruments Inc. (TXN) and UnitedHealth Group Inc. (UNH). As trading activity increasingly centers on company-specific catalysts – from earnings and guid
UnitedHealth Faces Sole Antitrust Spotlight As Valuation Gap Widens
CVS Health has reached a proposed settlement with the Federal Trade Commission in a major antitrust case focused on pharmacy benefit managers. The settlement leaves UnitedHealth Group (NYSE:UNH) as the sole remaining defendant in the U.S. government’s ongoing lawsuit. This shift increases regulatory focus on UnitedHealth Group’s pharmacy benefit manager operations and its role in the broader case. UnitedHealth Group, trading at $272.28, now faces concentrated attention in a high profile...
CVS, FTC reach proposed settlement in insulin pricing case
A settlement between CVS' pharmacy benefit manager and antitrust regulators would leave UnitedHealth as the sole holdout in high-profile suit.
Is It Worth Investing in UnitedHealth (UNH) Based on Wall Street's Bullish Views?
According to the average brokerage recommendation (ABR), one should invest in UnitedHealth (UNH). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Andrew Harris Joins Red Sky Health as Senior Vice President of Operations
Red Sky Health, providers of an AI-driven platform that delivers healthcare claim denials remediation, today announced that recognized healthcare analytics leader, Andrew Harris, has joined the company as Senior Vice President of Operations. In this role, Harris will be responsible for scaling delivery, sharpening execution, and ensuring Red Sky Health continues to bring measurable, repeatable impact to every provider and partner they serve. Using advanced proprietary AI models trained on large